Patent Assignment
Reel/Frame 015190/0939
Assignment of Assignor's Interest
Recorded: 2004-04-09
Pages: 3
Assignor
VIATRIS GMBH & CO. KG
Executed: 2004-01-24
Assignee
XCEL PHARMACEUTICALS, INC.
6363 GREENWICH DRIVE, SUITE 100, SAN DIEGO, CALIFORNIA, 92122
Covered Property
(1)
Novel Modifications of 2-Amino-4-(4-5FLUOROBENZYLAMINO)-1- Ethoxycarbonylaminobenzene, and Processes for Their Preparation
Patent:
5,914,425 →
Application:
09/004,926 →
Related Assignments
(15)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 24, 1998
From: MEISEL, PETER; LANDGRAF, KARL-FRIEDRICH; SCHAFER, JURGEN; THIEL, WILFRIED
To: ASTA MEDICAL AKTIENGESELLSCHAFT
Reel/Frame 009134/0328 →
Assignment of Assignor's Interest
Jul 9, 1998
From: MEISEL, PETER; LANDGRAF, KARL-FRIEDRICH; SCHAFER, JURGEN; THIEL, WILFRIED
To: ASTA MEDICAL AKTIENGESELLSCHAFT
Reel/Frame 009308/0906 →
Corrective Assignment to Correct the Name of the Assignee, Filed on 7/9/98, Recorded on Reel 9308, Frame 0906. Assignor Hereby Confirms the Assignment of the Entire Interest.
Jan 27, 1999
From: MEISEL, PETER; LANDGRAF, KARL-FRIEDRICH; SCHAFER, JURGEN; THIEL, WILFRIED
To: ASTA MEDICA AKTIENGESELLSCHAFT
Reel/Frame 009533/0787 →
Re-Record to Correct the Number of Microfilm Pages from 2 to 3 at Reel 9533, Frame 0787.
Jan 27, 1999
From: MEISEL, PETER; LANDGRAF, KARL-FRIEDRICH; SCHAFER, JURGEN; THIEL, WILFRIED
To: ASTA MEDICA AKTIENGESELLSCHAFT
Reel/Frame 010329/0059 →
Change of Name
Oct 21, 2002
From: ASTA MEDICA AG
To: VIATRIS GMBH & CO. KG
Reel/Frame 013386/0851 →
Release of Security Agreement
Mar 7, 2005
From: REGIMENT CAPITAL III, L.P.
To: XCEL PHARMACEUTICALS, INC.
Reel/Frame 015732/0626 →
Change of Name
Jun 17, 2008
From: XCEL PHARMACEUTICALS, INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 021109/0075 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Security Agreement
Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →